ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,235,033 | -33.9% | 2,808,034 | 0.0% | 10.68% | -25.4% |
| Q2 2023 | $29,119,313 | +28.2% | 2,808,034 | 0.0% | 14.32% | +21.5% |
| Q1 2023 | $22,716,995 | -48.6% | 2,808,034 | 0.0% | 11.79% | -37.6% |
| Q4 2022 | $44,226,536 | +0.1% | 2,808,034 | 0.0% | 18.89% | +32.9% |
| Q3 2022 | $44,198,000 | +12.8% | 2,808,034 | 0.0% | 14.21% | +34.7% |
| Q2 2022 | $39,200,000 | -21.6% | 2,808,034 | -3.1% | 10.56% | -24.5% |
| Q1 2022 | $49,979,000 | +1.1% | 2,899,034 | -14.7% | 13.98% | +37.5% |
| Q4 2021 | $49,422,000 | -19.2% | 3,399,034 | 0.0% | 10.17% | +12.9% |
| Q3 2021 | $61,183,000 | +2.5% | 3,399,034 | 0.0% | 9.01% | +11.7% |
| Q2 2021 | $59,687,000 | -30.3% | 3,399,034 | 0.0% | 8.07% | -21.4% |
| Q1 2021 | $85,656,000 | +1291.6% | 3,399,034 | +257.3% | 10.26% | +1433.6% |
| Q4 2020 | $6,155,000 | +1554.6% | 951,384 | +556.7% | 0.67% | +696.4% |
| Q3 2020 | $372,000 | -93.3% | 144,874 | -80.6% | 0.08% | -96.7% |
| Q4 2018 | $5,529,000 | -28.1% | 748,132 | +41.3% | 2.54% | +0.7% |
| Q3 2018 | $7,689,000 | -27.3% | 529,551 | 0.0% | 2.52% | -30.1% |
| Q2 2018 | $10,575,000 | +40.5% | 529,551 | +23.3% | 3.60% | +15.5% |
| Q1 2018 | $7,526,000 | +21.1% | 429,551 | +70.5% | 3.12% | -28.4% |
| Q4 2017 | $6,213,000 | – | 251,936 | – | 4.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |